mTOR controls ChREBP transcriptional activity and pancreatic β cell survival under diabetic stress

GC Chau, DU Im, TM Kang, JM Bae, W Kim… - Journal of Cell …, 2017 - rupress.org
GC Chau, DU Im, TM Kang, JM Bae, W Kim, S Pyo, EY Moon, SH Um
Journal of Cell Biology, 2017rupress.org
Impaired nutrient sensing and dysregulated glucose homeostasis are common in diabetes.
However, how nutrient-sensitive signaling components control glucose homeostasis and β
cell survival under diabetic stress is not well understood. Here, we show that mice lacking
the core nutrient-sensitive signaling component mammalian target of rapamycin (mTOR) in β
cells exhibit reduced β cell mass and smaller islets. mTOR deficiency leads to a severe
reduction in β cell survival and increased mitochondrial oxidative stress in chemical-induced …
Impaired nutrient sensing and dysregulated glucose homeostasis are common in diabetes. However, how nutrient-sensitive signaling components control glucose homeostasis and β cell survival under diabetic stress is not well understood. Here, we show that mice lacking the core nutrient-sensitive signaling component mammalian target of rapamycin (mTOR) in β cells exhibit reduced β cell mass and smaller islets. mTOR deficiency leads to a severe reduction in β cell survival and increased mitochondrial oxidative stress in chemical-induced diabetes. Mechanistically, we find that mTOR associates with the carbohydrate-response element–binding protein (ChREBP)–Max-like protein complex and inhibits its transcriptional activity, leading to decreased expression of thioredoxin-interacting protein (TXNIP), a potent inducer of β cell death and oxidative stress. Consistent with this, the levels of TXNIP and ChREBP were highly elevated in human diabetic islets and mTOR-deficient mouse islets. Thus, our results suggest that a nutrient-sensitive mTOR-regulated transcriptional network could be a novel target to improve β cell survival and glucose homeostasis in diabetes.
rupress.org